id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0779-0048,FDA,FDA-2014-D-0779,Current Good Manufacturing Practice - Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act Guidance for Industry,Other,Guidance,2020-01-23T05:00:00Z,2020,1,2020-01-23T05:00:00Z,,2024-11-12T23:16:13Z,,1,0,09000064842e238e